CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822082553
- Phone
- (781) 222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $654,036
- in 3 filings
Net −$654,036. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Dhingra Kapil Director | Option exercise | +43,169 | $1.75 | $76K | 43,169 |
| 2026-11-02 | Dhingra Kapil Director | Sale | −21,500 | $19.00 | $409K | 21,669 |
| 2026-11-02 | Dhingra Kapil Director | Option exercise · Stock Option (right to buy) | −43,169 | 0 | ||
| 2026-04-01 | Dhingra Kapil Director | Grant or award · Stock Option (right to buy) | +44,500 | 44,500 | ||
| 2025-12-09 | Dhingra Kapil Director | Option exercise | +3,169 | $1.75 | $6K | 3,169 |
| 2025-12-09 | Dhingra Kapil Director | Sale | −3,169 | $10.40 | $33K | 0 |
| 2025-12-09 | Dhingra Kapil Director | Option exercise · Stock Option (right to buy) | −3,169 | 0 | ||
| 2025-04-01 | Dhingra Kapil Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2024-04-01 | Dhingra Kapil Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 |
Page 1 of 1 · 9 trades